148 related articles for article (PubMed ID: 17895511)
1. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
[TBL] [Abstract][Full Text] [Related]
2. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies--a pilot study.
Sucker C; Hetzel GR; Farokhzad F; Dahhan F; Schmitz M; Kurschat C; Grabensee B; Maruhn-Debowski B; Zotz R; Scharf R
Nephrol Dial Transplant; 2007 May; 22(5):1347-50. PubMed ID: 17327284
[TBL] [Abstract][Full Text] [Related]
3. The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study.
Sucker C; Kurschat C; Farokhzad F; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Scharf RE; Zotz RB
Clin Appl Thromb Hemost; 2009; 15(3):283-8. PubMed ID: 19448163
[TBL] [Abstract][Full Text] [Related]
4. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
[TBL] [Abstract][Full Text] [Related]
5. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
Göpel W; Kattner E; Seidenberg J; Kohlmann T; Segerer H; Möller J;
J Pediatr; 2002 Jun; 140(6):688-92. PubMed ID: 12072871
[TBL] [Abstract][Full Text] [Related]
6. The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies.
Sucker C; Kurschat C; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Ostojic L; Scharf RE; Zotz RB
Clin Appl Thromb Hemost; 2009; 15(3):360-3. PubMed ID: 19448164
[TBL] [Abstract][Full Text] [Related]
7. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
[TBL] [Abstract][Full Text] [Related]
8. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhage.
Parmeggiani F; Costagliola C; Incorvaia C; Gemmati D; D'Angelo S; Tognazzo S; Scapoli GL; Sebastiani A
Am J Ophthalmol; 2004 Sep; 138(3):481-4. PubMed ID: 15364237
[TBL] [Abstract][Full Text] [Related]
11. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.
Bagheri M; Rad IA; Omrani MD; Nanbaksh F
Syst Biol Reprod Med; 2011 Oct; 57(5):261-4. PubMed ID: 21548851
[TBL] [Abstract][Full Text] [Related]
12. Factor XIII Val34Leu polymorphism is associated with increased factor XIII activation and decreased transcutaneous oxygen readings in patients with diabetic foot ulcers.
Küper MA; Schüle R; Mayer P; Königsrainer A; Beckert S
Diabet Med; 2012 Dec; 29(12):1596-9. PubMed ID: 22578139
[TBL] [Abstract][Full Text] [Related]
13. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
[TBL] [Abstract][Full Text] [Related]
14. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
de la Red G; Tàssies D; Espinosa G; Monteagudo J; Bové A; Plaza J; Cervera R; Reverter JC
Thromb Haemost; 2009 Feb; 101(2):312-6. PubMed ID: 19190815
[TBL] [Abstract][Full Text] [Related]
15. Factor XIII val34leu and the risk of myocardial infarction.
Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
[TBL] [Abstract][Full Text] [Related]
16. FXIII gene Val34Leu polymorphism in Turkish children with cerebral infarct.
Akar N; Dönmez B; Deda G
J Child Neurol; 2007 Feb; 22(2):222-4. PubMed ID: 17621488
[TBL] [Abstract][Full Text] [Related]
17. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis.
Vokó Z; Bereczky Z; Katona E; Adány R; Muszbek L
Thromb Haemost; 2007 Mar; 97(3):458-63. PubMed ID: 17334514
[TBL] [Abstract][Full Text] [Related]
18. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
[TBL] [Abstract][Full Text] [Related]
19. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
20. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
